Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-07-028896
Filing Date
2007-04-17
Accepted
2007-04-17 17:18:16
Documents
10
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a07-9489_110k.htm 10-K 2162762
2 EX-3.1 a07-9489_1ex3d1.htm EX-3.1 20356
3 EX-10.22 a07-9489_1ex10d22.htm EX-10.22 18715
4 EX-10.23 a07-9489_1ex10d23.htm EX-10.23 35911
5 EX-21 a07-9489_1ex21.htm EX-21 1296
6 EX-23 a07-9489_1ex23.htm EX-23 3563
7 EX-31.1 a07-9489_1ex31d1.htm EX-31.1 7357
8 EX-31.2 a07-9489_1ex31d2.htm EX-31.2 7351
9 EX-32.1 a07-9489_1ex32d1.htm EX-32.1 4888
10 EX-32.2 a07-9489_1ex32d2.htm EX-32.2 4893
  Complete submission text file 0001104659-07-028896.txt   2268629
Mailing Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170 2126729190
CALLISTO PHARMACEUTICALS INC (Filer) CIK: 0001142380 (see all company filings)

EIN.: 651107840 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32325 | Film No.: 07771627
SIC: 2834 Pharmaceutical Preparations